Grossman, Steven. 2010. Top 10 Things That Hill Staff Need to Know About FDA. http://strengthenfda.org/2010/03/06/top-10-%E2%80%9Cthings-that-hill-staff-need-toknow-about-fda%E2%80%9D/ (accessed August 2, 2010).
Harrill, A. H., P. B. Watkins, S. Su, P. K. Ross, D. E. Harbourt, I. M. Stylianou, G. A. Boorman, M. W. Russo, R. S. Sackler, S. C. Harris, and P. C. Smith, R. Tennant, M. Bogue, K. Paigen, C. Harris, T. Contractor, T. Wiltshire, I. Rusyn, and D. W. Threadgill. 2009. Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Research 19(9):1507–1515.
HHS (Department of Health and Human Services). 2010. Advancing the Health, Safety, and Well-Being of Our People. http://www.hhs.gov/asrt/ob/docbudget/2011budget inbrief.pdf (accessed December 21, 2010).
IOM (Institute of Medicine). 2007. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, DC: The National Academies Press.
IOM. 2008. Emerging Safety Science. Washington, DC: The National Academies Press.
IOTF (Interagency Oncology Task Force). 2010. Joint Fellowship Program. http://iotftraining.nci.nih.gov/ (accessed May 26, 2010).
Kim, S. 2010. Model of Data Sharing in IIRIS/COE. http://iom.edu/~/media/Files/Activity%20Files/Research/DrugForum/2010-FEB-26/Microsoft%20PowerPoint%20-%20Kim-IOM-2010-02-26%20FDA%20Centers%20of%20Excellence.ashx (accessed March 19, 2010).
NCI (National Cancer Institute). 2010. Clinical Trials Cooperative Group Program. http://www.cancer.gov/cancertopics/factsheet/NCI/clinical-trials-cooperative-group (accessed May 26, 2010).
NIH (National Institutes of Health). 2010. NIH and FDA Announce Collaborative Initiative to Fast-Track Innovations to the Public. http://www.nih.gov/news/health/feb2010/od24.htm (accessed August 5, 2010).
Nordenberg, D. 2010. Centers of Excellence in Regulatory Science Network. http://iom.edu/~/media/Files/Activity%20Files/Research/DrugForum/2010-FEB-26/Microsoft%20PowerPoint%20%20NordenbergIOM%20Ctrs%20of%20Excellence%20Feb%2026%202010%20v24.ashx (accessed March 19, 2010).
OMOP (Observational Medical Outcomes Partnership). 2010. About Us. http://omop.fnih.org (accessed March 26, 2010).
Peck, C. 2010. Centers of Excellence (COEs) in Regulatory and Information Science: Accelerating Development of Innovative Products and Ensuring the Public’s Health. Unpublished paper submitted to IOM Forum on Drug Discovery, Development, and Translation.
Research!America. 2010. America Speaks. http://www.researchamerica.org/uploads/AmericaSpeaksV10.pdf (accessed March 19, 2010).
Roses, A. 2010. IOM 26 Feb 2010 FDA Centers of Excellence for Regulatory Science. http://iom.edu/~/media/Files/Activity%20Files/Research/DrugForum/2010-FEB-26/Microsoft%20PowerPoint%20-%20Roses.pdf (accessed August 9, 2010).
Roses, A. D., M. W. Lutz, H. Amrine-Madsen, A. M. Saunders, D. G. Crenshaw, S. S. Sundseth, M. J. Huentelman, K. A. Welsh-Bohmer, and E. M. Reiman. 2009. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer’s Disease. Pharmacogenomics J. doi: 10.1038/tpj.2009.69.
The Scientist. 2009. More Regulatory Science—FDA Chief. http://www.the-scientist.com/blog/display/55984/ (accessed May 24, 2010).
Sigal, E. 2010. Opportunities for Enhancing Regulatory Science: A Blueprint to Benefit Patients. http://iom.edu/~/media/Files/Activity%20Files/Research/DrugForum/2010-FEB26/Microsoft%20PowerPoint%20-%20Sigal-IOM%20Reg%20Science%20FINAL.ashx (accessed March 19, 2010).
Skarke, C., and G. A. FitzGerald. 2010. Training translators for smart drug discovery. Science Translational Medicine 2(26):26cm12.